Search clinical trials for: BPH, benign prostatic hyperplasia

Total 7847 results

University Hospital, Rouen

Terminated

Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment. (Prost-EMBOL)

Benign Prostatic Hyperplasia

France
Warner Chilcott

Completed

Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Ferring Pharmaceuticals

Completed

A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) (DELUTS)

Lower Urinary Tract Symptoms (LUTS)

United States, Canada, Belgium, Czech Republic, Italy, Poland
The University of Texas Health Science Center,...

Withdrawn

BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia | Prostate Cancer | Enlarged Prostate With Lower Urinary Tract Symptoms (LUTS)

United States
Ferring Pharmaceuticals

Completed

Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.

BPH

Germany
Siami, Paul F., M.D.
GlaxoSmithKline; Pfizer

Completed

Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) (LUTS)

Benign Prostatic Hyperplasia (BPH)

United States
University of Magdeburg

Completed

Saline With Alcohol in TransUrethral Resection aNd Photoselective Vaporisation of the Prostate (SATURN-P)

Benign Prostatic Hypertrophy

Germany
St. Luke's Medical Center, Philippines
Philippine Board of Urology; Philippine Urology Residents Association

Completed

2013 Annual National Digital Rectal Exam (DRE) Day Study

Benign Prostatic Hyperplasia | Prostate Cancer | Prostatitis

Philippines
St. Luke's Medical Center, Philippines

Completed

Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome

Benign Prostatic Hyperplasia | Prostate Cancer | Prostatitis

Philippines
Health Ever Bio-Tech Co., Ltd.

Completed

MCS in the Treatment of Lower Urinary Tract Symptoms (MCS_LUTS)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
Health Ever Bio-Tech Co., Ltd.

Completed

Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c) (MCS-2-US-c)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
Assistance Publique - Hôpitaux de Paris

Completed

QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser) (QUAPELLA)

Benign Prostatic Hyperplasia

France
Dongkook Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride

Benign Prostate Hyperplasia

Korea, Republic of
Bayer

Completed

Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy

Prostatic Hypertrophy, Benign

Germany
Royal Victoria Hospital, Canada

Unknown

Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized Patients

Benign Prostate Hyperplasia | Urinary Retention

Canada
P. Square Medical Ltd

Suspended

Bladder Outlet Obstruction Observation Using Dynamic Urine Vibration "Holter"

Bladder Outlet Obstruction

Israel
Bayer

Completed

Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Germany
Dr. J. Curtis Nickel
University of California, Los Angeles; The Cleveland Clinic

Terminated

JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Benign Prostatic Hyperplasia | Chronic Prostatitis

Canada
Astellas Pharma Inc
Boehringer Ingelheim; Astellas Pharma Europe Ltd.

Completed

A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.

Benign Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)

Prostate Hyperplasia
Boehringer Ingelheim

Completed

FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Hanmi Pharmaceutical Company Limited

Completed

Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin

Benign Prostatic Hyperplasia | Erectile Dysfunction

Korea, Republic of
Assistance Publique Hopitaux De Marseille

Completed

Prostate Cancer Antigen 3 (PCA-3) Gene Project

Prostate Cancer | Benign Prostatic Hypertrophy

France
Royal Victoria Hospital, Canada
McGill University

Completed

Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP)

Benign Prostate Hyperplasia

Canada
Yonsei University

Completed

The Effective Concentration of Lidocaine With Fentanyl in Lumbar Epidural Anesthesia for Transurethral Resection of Prostate(TURP) in Elderly Patients

BPH( Benign Prostate Hyperplasia) | TURP(Transurethral Resection of Prostate)

Korea, Republic of
Yonsei University

Completed

Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study

Benign Prostate Hyperplasia | Bladder Tumor

Korea, Republic of
Buddhist Tzu Chi General Hospital

Completed

Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels

Benign Prostatic Hyperplasia

Taiwan
Seoul National University Hospital
Astellas Pharma Korea, Inc.; Medical Research Collaborating Center, Seoul,...

Unknown

Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients (ABSOLUTE)

Benign Prostate Hyperplasia

Korea, Republic of
Nymox Corporation

Completed

Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Nymox Corporation

Completed

Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
RECORDATI GROUP

Completed

Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia (SiRE)

Benign Prostatic Hyperplasia

Italy
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S, France

Completed

Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART) (ATTAC-PCO)

Polycystic Ovarian Syndrome

France
University of California, San Francisco

Completed

MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer

Prostate Cancer | Nonmalignant Neoplasm

United States
The Catholic University of Korea

Unknown

The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia | Chronic Kidney Failure

Korea, Republic of
Pierre Fabre Medicament

Completed

Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) (PERMIN)

Benign Prostatic Hyperplasia (BPH)

France, Spain, Portugal, Italy
Queen's University

Completed

Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia

BPH

Canada
Singapore General Hospital

Completed

To Compare Outcomes After Transurethral Enucleation of Prostate Versus Transurethral Resection of Prostate

Benign Prostatic Hyperplasia

Singapore
Fuzhou General Hospital

Completed

Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates

Benign Prostate Hyperplasia

China

3

Subscribe